Open AccessTherapeutic leukocyte reduction for acute and chronic myeloid leukemias: A 4-year experience from an oncology center in India
Author(s) -
Anita Tendulkar,
Puneet Jain,
Abhaykumar Malind Gupta,
Nidhi Sharma,
Anisha Navkudkar,
Vijaya Patle
Publication year - 2017
Publication title -
asian journal of transfusion science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.262
H-Index - 22
eISSN - 1998-3565
pISSN - 0973-6247
DOI - 10.4103/ajts.ajts_103_16
Subject(s) - medicine , oncology , center (category theory) , reduction (mathematics) , myeloid , myeloid leukemia , chemistry , geometry , mathematics , crystallography
Hyperleukocytosis (HL) and leukostasis seen in myeloid leukemias are a medical emergency. We present a case series of ten such patients in a 4-year period. Sixteen therapeutic leukocyte reduction (TLR) were done in ten cases along with other supportive measures. The American Society for Apheresis supports the routine implementation of TLR in cases of HL secondary to myeloid leukemias with signs of leukostasis.